BACKGROUND: In several lung diseases, oxidative stress can be demonstrated. This has not been shown in patients with ventilator-associated pneumonia (VAP). METHODS: We studied plasma and bronchoalveolar lavage (BAL) samples for markers of oxidative stress, taken from patients with VAP. Seventy-eight patients likely to have VAP and 10 patients who were not suspected of having VAP were studied prospectively. A diagnosis of VAP was based on a positive quantitative mini-lavage culture of > or = 10(3) colony-forming units per ml. Blood and BAL samples were collected and analysed for thiobarbituric acid reactant substances (TBARS) and antioxidant activity. RESULTS: Plasma and alveolar TBARS increased significantly in patients who developed VAP compared with those who did not, by 43% and 259% respectively. Red cells and alveolar glutathione peroxidase concentrations (antioxidant activity) were lower in those with VAP compared with the non-VAP group, by 43% and 68% respectively. No significant differences were found for serum superoxide dismutase activity. Significant differences were found for alveolar glutathione peroxidase concentrations over time in the VAP group. No significant differences between survivors and non-survivors were found in the blood or BAL assays, in patients with VAP. CONCLUSIONS: VAP is associated with evidence of early oxidative stress in the alveolar fluid and blood.
BACKGROUND: In several lung diseases, oxidative stress can be demonstrated. This has not been shown in patients with ventilator-associated pneumonia (VAP). METHODS: We studied plasma and bronchoalveolar lavage (BAL) samples for markers of oxidative stress, taken from patients with VAP. Seventy-eight patients likely to have VAP and 10 patients who were not suspected of having VAP were studied prospectively. A diagnosis of VAP was based on a positive quantitative mini-lavage culture of > or = 10(3) colony-forming units per ml. Blood and BAL samples were collected and analysed for thiobarbituric acid reactant substances (TBARS) and antioxidant activity. RESULTS: Plasma and alveolar TBARS increased significantly in patients who developed VAP compared with those who did not, by 43% and 259% respectively. Red cells and alveolar glutathione peroxidase concentrations (antioxidant activity) were lower in those with VAP compared with the non-VAP group, by 43% and 68% respectively. No significant differences were found for serum superoxide dismutase activity. Significant differences were found for alveolar glutathione peroxidase concentrations over time in the VAP group. No significant differences between survivors and non-survivors were found in the blood or BAL assays, in patients with VAP. CONCLUSIONS: VAP is associated with evidence of early oxidative stress in the alveolar fluid and blood.
Authors: Ignacio Garutti; Francisco De la Gala; Patricia Piñeiro; Lisa Rancan; Elena Vara; Almudena Reyes; Luis Puente-Maestu; Jose María Bellón; Carlos Simón Journal: J Clin Monit Comput Date: 2019-01-17 Impact factor: 2.502
Authors: M Corradi; P Pignatti; P Manini; R Andreoli; M Goldoni; M Poppa; G Moscato; B Balbi; A Mutti Journal: Eur Respir J Date: 2004-12 Impact factor: 16.671
Authors: Mette M Berger; Philippe Eggimann; Daren K Heyland; René L Chioléro; Jean-Pierre Revelly; Andrew Day; Wassim Raffoul; Alan Shenkin Journal: Crit Care Date: 2006 Impact factor: 9.097
Authors: Ebru S Parlak; Murat Alisik; Habibe Hezer; Aysegul Karalezli; Hatice C Hasanoglu; Ozcan Erel Journal: Saudi Med J Date: 2018-05 Impact factor: 1.484
Authors: Mojtaba Sharafkhah; Ali Abdolrazaghnejad; Nader Zarinfar; Abolfazl Mohammadbeigi; Ali Massoudifar; Sahand Abaszadeh Journal: Med Gas Res Date: 2018-04-18